Answers are grounded in this paper and cite their sources.
Population surveillance demonstrates decreased invasive pneumococcal disease in young children and adults, suggesting effective control of drug-resistant strains.
The use of the pneumococcal conjugate vaccine is preventing disease in young children, for whom the vaccine is indicated, and may be reducing the rate of disease in adults. The vaccine provides an effective new tool for reducing disease caused by drug-resistant strains.
No takes yet. Share an insight, caveat, or question.
Whitney et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: